R7Y-30962-71279 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-26
Dose 1 — Pfizer-BioNTech
2021-04-14
Dose 2 — Pfizer-BioNTech
2021-10-21
Registered in v-safe
2021-10-21
Dose 3 — Pfizer-BioNTech
2021-10-21
Health check-in — day 0, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-10-22
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Chills, Muscle or body aches

Adult check-in
2021-10-23
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Nausea

Adult check-in
2021-10-24
Survey response — days 1–6 daily, dose 3
MedDRA: Tachycardia — Feeling: Fair · Site: Swelling · Nausea

Free text: Taquicardia

MedDRA releases: 2024-11 · check-in free text available
2021-10-25
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-10-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-27
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-28
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-11-04
Survey response — day 14, dose 3
MedDRA: Dizziness, Nausea, Pain in extremity — Feeling: Fair

Free text: Dizziness and nauseas, my feet are hurting me

MedDRA releases: 2024-11 · check-in free text available
2021-11-11
Survey response — day 21, dose 3
MedDRA: Headache, Nausea — Feeling: Fair

Free text: Headache, nauseas

MedDRA releases: 2024-11 · check-in free text available
2021-11-18
Survey response — day 28, dose 3
MedDRA: Migraine, Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Migraines, nauseas

MedDRA releases: 2024-11 · check-in free text available
2021-11-25
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-12-02
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-01-23
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-04-23
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-10-23
Survey response — 12 months, dose 3
MedDRA: Headache, Pharyngeal swelling — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Headaches. From time to time my throat gets swollen for no reason

MedDRA releases: 2024-11 · check-in free text available
2022-10-23
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-10-25
Call successful
Not applicable - Accidental Reporting

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-26	Pfizer-BioNTech	No
2	2021-04-14	Pfizer-BioNTech	No
3	2021-10-21	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-24

Systemic reaction (other): Taquicardia

Release 10 — day 14, dose 3

2021-11-04

Symptoms: Dizziness and nauseas, my feet are hurting me

Release 10 — day 21, dose 3

2021-11-11

Symptoms: Headache, nauseas

Release 10 — day 28, dose 3

2021-11-18

Symptoms: Migraines, nauseas

Release 12 — 12 months, dose 3

2022-10-23

Symptoms: Headaches. From time to time my throat gets swollen for no reason

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dizziness	·	·	✓
SD	Headache	·	·	✓
SD	Migraine	·	·	✓
SD	Nausea	·	·	✓
SD	Pain in extremity	·	·	✓
SD	Pharyngeal swelling	·	·	✓
SRO	Tachycardia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release